Patients being treated for cancer are at high risk for infectious complications, generally due
to colonizing organisms that gain access to sterile sites via disrupted epithelial barriers …

Febrile neutropenia (FN) in children treated for malignancy is a common and direct sequela
of chemotherapy. Episodes of FN can be life-threatening, and demand prompt recognition …

Background High-risk febrile neutropenia (HR-FN) is a life-threatening complication in
patients with haematological malignancies or receiving myelosuppressive chemotherapy …

Abstract Viridans Group Streptococci (VGS) are associated with high mortality rates in febrile
neutropenia; yet there are no recent European pediatric studies to inform antimicrobial …

SUMMaRY anginosus group-32.6%, S. sanguinis group-16.3%, S. mutans group-12.2%,
and S. salivarius group-6.1%. The rates of resistance and reduced sensitivity of the isolates …

Patients with hematologic malignancy (HM) and individuals undergoing stem cell
transplantation (SCT) are particularly vulnerable to bacterial infections for several reasons …

The aim of this review is to present an update on the susceptibility of viridans group
streptococci (VGS) to β-lactam antimicrobials, with emphasis on the Argentinean scenario …

This study assessed the microbiology, clinical syndromes, and outcomes of oncologic
patients with viridans group streptococci isolated from blood cultures between January 1st …

In this issue of Clinical Infectious Diseases, Shelburne et al report their development and
validation of a clinical prediction model for β-lactam resistance in viridans group streptococci …

Streptococcus mitis/oralis group isolates with reduced carbapenem susceptibility have been
reported, but its isolation rate in Japan is unknown. We collected 356 clinical α-hemolytic …